Dey DuoNeb
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
First dual-therapy (albuterol and ipratropium) nebulizer solution to treat bronchospasm with chronic obstructive pulmonary disease is approved March 21. The inhalation solution is for use in patients requiring more than one bronchodilato